-
MannKind Loses 6% Following Death Of Alfred Mann & Business Update Concerning Annual Report
Friday, February 26, 2016 - 12:29pm | 311Read More...Shares of MannKind Corporation (NASDAQ: MNKD) were trading lower by 6 percent on Friday after the company sadly announced the death of Alfred E. Mann. Mann was the founder of MannKind and served as its Chairman from 2001 until February 2016. Mann also founded and largely founded 14 companies in...
-
MannKind Issues Management Update
Monday, January 11, 2016 - 3:44pm | 220Read More...Shares of MannKind Corporation (NASDAQ: MNKD) were trading slightly higher by 1.58 percent at $0.67 mid-Monday afternoon after the company provided an update on its senior management team. MannKind has withdrawn its offer to employ Duane M. DeSisto as its new CEO. The company cited "...
-
MannKind Founder Becomes Chairman, President Hakan Edstrom Becomes New CEO
Monday, January 12, 2015 - 9:26am | 115Read More...MannKind Corporation (NASDAQ: MNKD) announced Monday that Alfred Mann, the company's founder, retired from his role as Chief Executive Officer effective January 9, 2015, and will transition to Executive Chairman. Mann intends to remain engaged with the company in business matters, including...
-
MannKind Corp (MNKD) Expects FDA Approval For Its Insulin Product
Wednesday, January 13, 2010 - 3:56pm | 120Read More...MannKind Corp (NYSE: MNKD) said that it expects the FDA to approve its experimental inhaled insulin device "within days" of inspecting a manufacturing plant that supplies the insulin. Alfred E. Mann , the company’s CEO, said that the FDA has so far inspected one of the two N.V. Organon...

